Skip to content

Press Release

Illumina Appoints Paula Dowdy Senior Vice President and General Manager of Commercial Operations for Europe, the Middle East and Africa

SAN DIEGO--(BUSINESS WIRE)--Jun. 2, 2016-- Illumina, Inc. (NASDAQ: ILMN) today announced that it has appointed Paula Dowdy to lead the Europe, Middle East and Africa (EMEA) commercial team as Senior Vice President and General Manager. Paula was previously Senior Vice President for Cloud, Software, and Managed Services at Cisco.

This Smart News Release features multimedia. View the full release here:http://www.businesswire.com/news/home/20160602005365/en/

Paula Dowdy (Photo: Business Wire)

“We are truly excited for Paula to lead our EMEA commercial operations team,” said Christian Henry, Executive Vice President for Commercial Operations. “Paula brings a proven track record of leadership, insight and execution, and her passion for delivering customer success will serve the EMEA region exceptionally well. Additionally, this hire supports our strategy to bring in expertise from large-scale companies to complement our leadership team.”

Paula joined Cisco 20 years ago and has spent the majority of her career in Europe. She has held numerous senior positions leading Cisco product and services groups for virtually all customer segments. In her most recent role, Paula led Cisco’s go-to-market team for Cloud, Software, and Managed Services where she drove the incubation of innovative new solutions.

Paula holds an MBA degree from Pepperdine University and a Bachelor of Arts degree from the University of California, Berkeley. Paula will officially join Illumina August 1, 2016.

About Illumina

Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture and other emerging segments. To learn more, visit www.illumina.com and follow @illumina.

Source: Illumina, Inc.

Illumina, Inc.
Investors:
Rebecca Chambers
858-255-5243
IR@illumina.com
or
Media:
Eric Endicott
858-882-6822
PR@illumina.com

Recent Articles

Ensuring Access to Genetic Testing
Ensuring Access to Genetic Testing
Minutes Matter. New PCR-Free Prep Expedites Whole-Genome Sequencing
Minutes Matter. New PCR-Free Prep Expedites Whole-Genome Sequencing
Illumina Acquires Enancio’s Compression Software
Illumina Acquires Enancio’s Compression Software